Insulin resistance and associated metabolic abnormalities in muscle: effects of exercise
A. Pérez-Martin
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorE. Raynaud
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorJ. Mercier
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorA. Pérez-Martin
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorE. Raynaud
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorJ. Mercier
Service Central de Physiologie Clinique, Unité CERAMM (Centre d'Exploration et de Réadaptation des Anomalies Métaboliques et Musculaires). CHU Lapeyronie 34295 Montpellier Cedex 5 FRANCE
Search for more papers by this authorSummary
Skeletal muscle is a major site of insulin resistance. In addition to glucose transport, oxidative disposal and storage defects, insulin resistant muscle exhibit many other metabolic abnormalities. After a brief review of insulin resistance determinants, we will focus on muscular abnormalities in obesity and type 2 diabetes. Glucose and lipid metabolism defects will be analysed and their interactions discussed. Exercise can improve many of these muscular abnormalities and the mechanisms underlying exercise-induced benefits have been clarified during the past decades. Therefore, exercise training has proved to be useful in the management of insulin resistant states, i.e. mainly obesity, especially in its truncal distribution, and type 2 diabetes. However, exercise prescription remains poorly codified, and results on glycaemic control are sometimes conflicting. In the last part of this review, we will emphazise the pathophysiological basis for an individualized exercise prescription in insulin resistant subjects.
References
- 1 Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S & Pedersen O. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828–832.
- 2 Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K & Winther K et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995; 346: 397–402.
- 3 Groop LC, Kankuri M, Schalin-Jantti C, Ekstrand A, Nikula-Ijar P, Widen E, Kuismanen E, Eriksson J, Fransisila-Kallunki A & Saloranta C et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Eng J Med 1993; 328: 10–14.
- 4 Zouali H, Velho G & Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 1568–1569.
- 5 Hansen L, Hansen T, Vestergaard H, Bjorbaek C, Echwald SM, Clausen JO, Chen YH, Chen MX, Cohen PT & Pedersen O. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet 1995; 4: 1313–1320.
- 6 Yki-Järvinen H. Sex and insulin sensitivity. Metabolism 1984; 33: 1011–1015.
- 7 Nuutila P, Knuuti MJ, Mäki M, Laine H, Ruotsalainen U, Teras M, Haaparanta M, Solin O & Yki-Jarvinene H. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 1995; 44: 31–36.
- 8 Ravussin E, Lillioja S & Knowler WC et al. Reduced rate of energy expenditure as a risk factor for body weight gain. N Engl J Med 1988; 318: 467–472 .
- 9 Pasquali R, Cantobelli S & Casimirri F et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993; 77: 341–346.
- 10 Krotkiewski M, Björntorp P, Sjörstrom L & Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150–1162.
- 11 Peiris AN, Struve MF, Mueller RA, Lee MB & Kissebach AH. Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 1988; 67: 760–767.
- 12 Rossel R & Belfrage E. Blood circulation in adipose tissue. Physiol Rev 1979; 59: 1078–1104.
- 13 Lonnqvist F, Thorne A, Nilsell K, Hoffstedt J & Arner P. A pathogenic role of visceral β3-adrenoreceptors in obesity. J Clin Invest 1995; 95: 1109–1116.
- 14 Hales CN, Barker DJP, Clark PMS, Cox LJ, Fall C & Osmond C. Fetal and infant growth and impaired glucose tolerance at age 64. Br Med J 1991; 303: 1019–1022.
- 15 Phillips DIW, Barker DJP, Hales CN, Hirst S & Osmond C. Thinnes at birth and insulin resistance in later life. Diabetologia 1994; 37: 150–154 .
- 16 Facchini FS, Hollenbeck CB, Jeppesen J, Chen YDI & Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128–1130.
- 17 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
- 18 Ericksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C & Groop L. Early metabolic defects in person at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989; 321: 337–343.
- 19 Simoneau J-A, Colberg SR, Thaete FL & Kelley DE. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995; 9: 273–278.
- 20 Baron AD, Brechtel G, Wallace P & Edelman SV. Rates and tissue sites of non-insulin and insulin-mediated glucose uptake in human. Am J Physiol 1998; 255: E769–E774.
- 21 Baron AD, Laakso M, Brechtel G & Edelman SV. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in non-insulin dependent diabetic subjects. J Clin Invest 1991; 87: 1186–1194.
- 22 Lillioja S, Young AA & Culter CL. Skeletal muscle capillarity density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987; 80: 415–424.
- 23 Lithell H, Landqvist G, Nygaard E, Versby B & Sattin B. Bodyweight, skeletal muscle morphology, and enzyme activities in relation to fasting serum fasting insulin concentrations and glucose tolerance in 48-year-old men. Diabetologia 1985; 30: 19–25.
- 24 Ganrot PO. Insulin resistance syndrome: possible key role of blood flow in resting muscle. Diabetologia 1993; 36: 876–879.
- 25 Holmang A, Brezinski Z & Björntorp P. Effetcs of hyperinsulinemia on muscle fiber composition and capillarization in rats. Diabetes 1993; 42: 1073–1081.
- 26 Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ & Dohm GL. Insulin receptor phosphorylation, insulin substrate-1 phosphorylation and phosphatidylinositol 3-kinase are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195–2204.
- 27 Bonadonna RC, Del Prato S, Bonora E, Saccomani MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C & De Fronzo R. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 1996; 45: 915–925.
- 28 Zierath JR, Krook A & Wallberg-Henriksson H. Insulin action in skeletal muscle from patients with NIDDM. Mol Cell Biochem 1998; 182: 153–160.
- 29 Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA & Holloszy JO. Recruitment of Glut 4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 1990; 172: 728–736.
- 30 Douen AG, Ramlal T, Rastogi S, Bilan PJ, Carti GD, Vranic M, Holloszy JO & Klip A. Exercise induces recruitment of the “insulin-responsive glucose transporter”: evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem 1990; 265: 13427–13430.
- 31 Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS & Kahn BB. Evidence against altered expression of Glut 1 or Glut 4 of skeletal muscle of patients with obesity or NIDDM. Diabetes 1990; 39: 865–870.
- 32 Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ & Horton ES. Acute exercise induces GLUT 4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999; 48: 1192–1197.
- 33 Zierath JR, He L, Guma A, Odegoard Wahlstrom E, Klip A & Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane Glut 4 content in skeletal muscle of patients with NIDDM. Diabetologia 1996; 39: 1180–1189.
- 34 Garvey WT, Maianu L, Zhu JH, Brechtel-Hook G, Wallace P & Baron AD. Evidence for defects in the trafficking and translo-cation of Glut 4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998; 101: 2377– 2386.
- 35 Echwald SM, Bjorbaek C, Hansen T, Clausen JO, Vestergaard H, Zierath JR, Printzm RL, Granner DK & Pedersen O. Identification of four amino acid substitutions in hexokinase II, and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes 1995; 44: 347–353.
- 36 Vestergaard H, Bjorbaek C, Hansen T, Larsen FS, Granner DK & Pedersen O. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. J Clin Invest 1995; 96: 2639–2645.
- 37 Arora KK, Parry DM & Pedersen PL. Hexokinase receptors: preferential enzyme binding in normal cells to nonmitochondrial sites, and in transformed cells to mitochondrial sites. J Bioenerg Biomembr 1992; 24: 47–53.
- 38 Simoneau J-A & Kelley DE. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 1997; 83: 166–171.
- 39 Shulman RG, Bloch G & Rothman DL. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proc Natl Sci USA 1995; 92: 8535–8542.
- 40 Thorburn AW, Gumbiner B, Bulacan F, Brechtel G & Henry RR. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 1991; 87: 489–495.
- 41 Damsbo P, Vaag A, Hother-Nielsen O & Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1991; 34: 239–245.
- 42 Nikoulina SE, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS & Henry RR. Regulation of glycogen synthase activity in cultured skeletal cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia. Diabetes 1997; 46: 1017–1024.
- 43 Golay A & Felber JP. Evolution from obesity to diabetes. Diabete Metab 1994; 20: 3–14.
- 44 Felberg JP, Haesler E & Jéquier E. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 1993; 36: 1221–1229.
- 45 Gerbitz K-D, Gempel K & Brdiczka D. Mitochondria and diabetes: genetic, biochemical and clinical implications of the cellular energy circuit. Diabetes 1996; 45: 113–116.
- 46 Ranneries C, Bülow J, Buemann B, Christensen NJ, Madsen J & Astrup A. Fat metabolism in formely obese women. Am J Physio 1998; 274: E155–E161.
- 47 Schutz Y, Tremblay A, Weinsner RL & Nelson KM. Role of fat oxidation in the long-term stabilization of body weight in obese women. Am J Clin Nutr 1992; 55: 670–674.
- 48 Ballor DL, Harvey-Berino JR, Ades PA, Cryan J & Calles-Escandon J. Decrease in fat oxidation following a meal in weight-reduced individuals: a possible mechanism for weight recidivism. Metabolism 1996; 45: 174–178.
- 49 Fraze E, Donner C, Swislocki A, Chiou Y, Chen Y & Reaven G. Ambient plasma free fatty acid concentrations in non insulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab 1985; 61: 807–811.
- 50 Kempen KP, Saris WH, Kuipers H, Glatz JF & Van Der Vusse GJ. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content. Eur J Clin Invest 1998; 28: 1030–1037.DOI: 10.1046/j.1365-2362.1998.00383.x
- 51 Van Der Vusse GJ, Glatz JFC, Stam HCG & Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992; 72: 881–940.
- 52 Ruderman NB, Saha AK, Vavvas D, Kuroski T, Laybutt DR, Schmitz-Peiffer C, Biden T & Kraegen EW. Malonyl-CoA as a metabolic switch and a regulator of insulin sensitivity. Adv Exp Med Biol 1998; 441: 263–270.
- 53 Colberg SR, Simoneau J-A, Thaete FL & Kelley DE. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 1995; 95: 1846–1853.
- 54 Bouchard C, Tremblay A, Després J-P, Nadeau A, Lupien PJ, Theriault G, Dussault J, Moorjani S, Pinault S & Fournier G. The response to long-term overfeeding in identical twins. N Engl J Med 1990; 322: 1477–1482.
- 55
Randle PJ,
Hales CN,
Garland PB &
Newsholme EA.
The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.
Lancet
1963; I: 785–789.
10.1016/S0140-6736(63)91500-9 Google Scholar
- 56 Randle PJ, Newsholme EA & Garland PB. Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscle. Biochem J 1964; 93: 652–665.
- 57 Bonadonna RC, Zych K, Boni C, Ferrannini E & De Fronzo RA. Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 1989; 257: E49–E56.
- 58 Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E & Smith C. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 1991; 88: 960–966.
- 59 Carey DG, Jenkins AB, Campbell LV, Freund J & Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women. Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45: 633–638.
- 60 Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW & Schulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97: 2859–2865.
- 61 Dressner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF & Schulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 1999; 103: 253–259.
- 62 De Fea K & Roth RA. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry 1997; 36: 12939–12947.
- 63 Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB & Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997; 46: 983–988.
- 64 Saha AK, Kurowski TG & Ruderman NB. A malonyl-CoA fuel sensing mechanism in muscle: effects of insulin, glucose and denervation. Am J Physiol 1995; 269: E283–E289.
- 65 MacGarry JD. Glucose–fatty acid interaction in health and disease. Am J Clin Nutr 1998; 67: 500S–504S.
- 66 Awan MN & Seggerson ED. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem J 1993; 295: 61–66.
- 67 Saha AK, Vavvas D, Kurowski TG, Apazidis A, Witters LA, Shafrir E & Ruderman NB. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol 1997; 272: E641–E648.
- 68 Taskinen M, Bogardus C, Kennedy A & Howard B. Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes mellitus. J Clin Invest 1985; 76: 637–644.
- 69 Kelley DE & Simoneau J-A. Impaired free fatty acid utilization by skeletal muscle in non-insulin dependent diabetes mellitus. J Clin Invest 1994; 94: 2349–2356.
- 70 Kelley D, Mokan M & Mandarino L. Intracellular defects in glucose metabolism in obese patients with NIDDM. Diabetes 1992; 41: 698–706.
- 71 Groop LC, Bonadonna RC, Simonon DC, Petrides AS, Shank M & De Fronzo RA. Effects of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol 1992; 263: E79–E84.
- 72 Winder W, Arogyasami WJ, Elayan IM & Vehrs PB. Muscle malonyl-CoA decreases during exercise. J Appl Physiol 1989; 67: 2230–2233.
- 73 Odland LM, Heigenhauser GJF, Lopaschuk GD & Spriet LL. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am J Physiol 1996; 270: E541–E544.
- 74 Odland LM, Howlett RA, Heigenhauser GJF, Hultman E & Spriet LL. Skeletal muscle malonyl-CoA at the onset of exercise at varying power outputs in human. Am J Physiol 1998; 274: E1080–E1085.
- 75 Hargreaves M, Kiens B & Richter AE. Effect of plasma free fatty acid concentration on muscle metabolism in exercising men. J Appl Physiol 1991; 70: 194–210.
- 76 Coyle EF, Jeukendrup AE, Wagenmakers AJM & Saris WHM. Fatty acid oxidation id directly regulated by carbohydrate metabolism during exercise. Am J Physiol 1997; 273: E268–E275.
- 77 Horowitz JF, Mora-Rodriguez R, Byerley LO & Coyle EF. Lipolytic suppression following carbohydrate ingestion limits fat oxidation during exercise. Am J Physiol 1997; 273: E768–E775.
- 78 Vanninen E, Uusitupa M, Siitonen O & Laitinen Länsilies E. Habitual physical activity, aerobic capacity and metabolic control in patients with newly diagnosed type 2 (non-insulin dependent) diabetes mellitus: effects of one year diet and exercise intervention. Diabetologia 1992; 35: 340–346.
- 79 Lehmann R, Vokac A, Niedermann K, Agosti K & Spinas GA. Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 1995; 38: 1313–1319.DOI: 10.1007/s001250050429
- 80 Ruderman NB, Ganda OP & Johensen K. Effects of physical training on glucose tolerance and plasma lipids in matury onset diabetes mellitus. Diabetes 1979; 28: 89–92.
- 81 Wood PD, Stefanik ML, Dreon DM, Frey-Hewitt B, Garrey SC, Williams PT, Superko HR, Fortmann SP, Albers JJ, Vranizan KM, Ellsworth NM, Terry RB & Haskell WL. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1988; 319: 1173–1179.
- 82 Williams PT, Krauss RM, Vranizan KM & Wood PD. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss an moderately overweight men. Circulation 1990; 81: 1293–1304.
- 83 Sunami Y, Motoyama M, Kinoshita F, Mizooka Y, Sueta K, Matsunaga A, Sasaki J, Tanaka H & Shindo M. Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects. Metabolism 1999; 48: 984–988.
- 84 Brownell KD. Exercise and obesity treatment: psychological aspects. Int J Obes 1995; 19: S122–S125.
- 85 Zierath JR & Wallberg-Henriksson H. Exercise training in obese diabetic patients. Special considerations. Sports Med 1992; 14: 171–189.
- 86 Rice B, Janssen I, Hudson R & Ross R. Effects of aerobic or resistant exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 1999; 22: 684– 691.
- 87 De Fronzo RA, Sherwin RS & Kraemer N. Effects of physical training on insulin action in obesity. Diabetes 1996; 36: 1379–1385.
- 88 Dengel DR, Pratley RE, Hagberg JM, Rogus EM & Goldberg AP. Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men. J Appl Physiol 1996; 81: 318–325.
- 89 Mikines KJ, Farrell PA, Sonne B, Tronier B & Galbo H. Effect of physical training on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988; 254: E248–E259.
- 90 Brun JF, Guintrand-Hugret R, Boegner C, Bouix O & Orsetti A. Influence of short submaximal exercise on parameters of glucose assimilation analyzed with the minimal model. Metabolism 1995; 44: 833–840.
- 91 Devlin JT, Hirsham M, Horton ED & Horton ES. Enhanced periphical and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 1987; 36: 434–439.
- 92 Hardin D, Azzarelli B, Edwards J, Wigglesworth J, Maianu L, Brechtel G, Johnson A & Garvey T. Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT-4 in skeletal muscle. J Clin Endocrinol Metab 1995; 80: 2437–2446.
- 93 Phillips SM, Han XX, Green H & Bonen A. Increments in skeletal muscle Glut-1 and Glut-4 after endurance traning in humans. Am J Physiol 1996; 270: E456–E462.
- 94 Dela F, Larsen JJ, Mikines KJ, Ploug T, Petersen LN & Galbo H. Insulin-stimulated muscle glucose clearance in patients with NIDDM. effects of one-legged physical training. Diabetes 1995; 44: 1010–1020.
- 95 Vukovich MD, Arciero PJ, Kohrt WM, Racette SB, Hansen PA & Holloszy JO. Changes in insulin action and Glut 4 with 6 days of inactivity in endurance runners. J Appl Physiol 1996; 80: 240–244.
- 96 Ryan AS, Pratley RE, Goldberg AP & Elahi D. Resistive training increases insulin action in postmenopausal women. J Gerontol 1996; 51A: M199–M205.
- 97 Miller JP, Pratley RE, Goldberg AP, Gordon P, Rubin M, Treuth MS, Ryan AS & Hurley BF. Strength training increases insulin action in healthy 50- to 60-yr-old men. J Appl Physiol 1994; 77: 1122–1127.
- 98 Miller W, Sherman WM & Ivy JL. Effect of strength training on glucose tolerance and post-glucose insulin response. Med Sci Sports Exerc 1984; 16: 539–543.
- 99 Tesch P. Skeletal muscle adaptations to long-term heavy resistance training. Med Sci Sports Exerc 1988; 20: S132–S134.
- 100 Ericksson J, Taimela S, Erikson K, Parviainen S, Peltonen J & Kujala U. Resistance training in the treatment of non-insulin dependent diabetes mellitus. Int J Sports Med 1997; 18: 242– 246.
- 101 Garrow JS & Summerbell CD. Meta-analysis: effects of exercise, with or without dieting, on the body composition of overweight subjects. Eur J Clin Nutr 1995; 49: 1–10.
- 102 Mertens DJ, Kavanagh T, Campbell RB & Shepard RJ. Exercise without dietary restriction as a mean to long-term fat loss in the obese cardiac patient. J Sport Med Phys Fitness 1998; 38: 310–316.
- 103 Svendsen OL, Krotkiewski M, Hassager C & Christiansen C. Effects on muscles of dieting with or without exercise in overweight postmenopausal momen. J Appl Physiol 1996; 80: 1365–1370.
- 104 Pavlou KN, Krey S & Steffee W. Exercise as an adjunct to weight loss and maintenance in moderately obese subjects. Am J Clin Nutr 1989; 49: 1115–1123.
- 105 Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E & Wolfe RR. Regulation of endogenous fat carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol 1993; 265: E380–E391.
- 106 Turcotte LP, Richter EA & Kiens B. Increased plasma FFA uptake and oxidation during prolonged exercise in trained vs untrained humans. Am J Physiol 1992; 262: E791–E799.
- 107 Martin WH, 3rd. Effects of acute and chronic exercise on fat metabolism. Exerc Sport Sci Rev 1996; 24: 203–231.
- 108 Coggan AR, Kohrt WM, Spina RJ, Bier DM & Holloszy JO. Endurance training decreases plasma glucose turnover and oxidation during moderate intensity exercise in man. J Appl Physiol 1990; 68: 990–996.
- 109 Martin WH, Dalsky GP, Hurley BF, Matthews DE, Bier DM, Hagberg JM, Rogers MA, King DS & Holloszy JO. Effect of endurance training on plasma FFA turnover and oxidation during exercise. Am J Physiol 1993; 265: E708–E714.
- 110 Nicklas BJ, Rogus EM & Golberg AP. Exercise blunts declines in lipolysis and fat oxidation after dietary-induced weight loss in obese older women. Am J Physiol 1997; 273: E149–E155.
- 111 Buemann B, Astrup A & Christensen NJ. Three months aerobic training fails to affect 24-hour energy expenditure in weight-stable, post-obese women. Int J Obes 1992; 16: 809–816.
- 112
American Diabetes Association. Diabetes mellitus and exercise.
Diab Care
1998; 21: S40–S44.
10.2337/diacare.21.1.S40 Google Scholar
- 113 Basdevant A, Laville M & Ziegler O. Practice guideline for the diagnosis, prevention and treatment of obesity in France. Groupe de travail chargé de la mise au point des ‘Recommandations pour le diagnostic, la prévention et le traitement des obésites en France’. Diabetes Metab 1995; 24: 10–42.
- 114 Tremblay A, Simoneau J-A & Bouchard C. Impact of exercise intensity on body fatness and skeletal muscle metabolism. Metabolism 1994; 43: 814–818.
- 115 Mulla NA, Simonsen L & Bulow J. Post-eexrcise adipose tissue and skeletal muscle lipid metabolism in human: the effects of exercise intensity. J Physiol 2000; 3: 919–928.
- 116 Helmrich SP, Ragland DR, Leung RW & Paffenbarger RS. Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus. N Engl J Med 1991; 325: 147–152.
- 117 Kriska AM & Benhent PH. An epideliological perspective of the relationship between physical activity and NIDDM. from activity assessment to intervention. Diabetes Metab Rev 1992; 8: 355–372.
- 118 Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennet PH, Tuomilehto J, Schersten B & Pettitt DJ. Preventing non-insulin dependent diabetes. Diabetes 1995; 14: 483–488.
- 119 Lynch J, Helmrich SP, Lakka TA, Kaplan GA, Cohen RD, Salonen R & Salonen JT. Moderately intense physical activities and high level of cardiorespiratory fitness reduce the risk of non-insulin dependent diabetes mellitus in middle-aged men. Arch Int Med 1996; 156: 1307–1314.
- 120 Manson JAE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC & Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. J Am Med Ass 1992; 268: 63–67.
- 121 Pan X-R, Li G-W, Hu Y-H, Wang J-X, Yang W-Y, An Z-X, Hu Z-X, Lin J, Xiao J-Z, Cao H-B, Liu P-A, Jiang X-G, Jiang Y-Y, Wang J-P, Zheng H, Zhang H, Bennett PH & Howard BV. The Da Qing IGT and diabetes study. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997; 20: 537–544.
- 122 Perry IJ, Wannamethe SG, Walker MK, Thompson AG, Whincup PH & Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged british men. Br Med J 1995; 310: 560–564.
- 123 Leermarkers EA, Dunn AL & Blair SN. Exercise management of obesity. Med Clin North Am 2000; 84: 419–440.
- 124 Serres I, Varray A, Vallet G, Micallef J-P & Préfaut C. Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary desease. J Cardiopulm Rehabil 1997; 17: 232–238.
- 125 Serres IV, Gautier V, Varray A & Préfaut C. Impaired skele- tal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest 1998; 113: 900– 905.
- 126 Krotkiewski M & Björntorp P. Muscle tissue in obesity with different distributions of adipose tissue: effects of physical training. Int J Obes 1986; 10: 331–341.
- 127 Peronnet F & Massicote D. Table of non-protein respiratory quotient; an update. Can J Sport Sci 1991; 16: 23–29.
- 128 Brooks GA & Mercier J. Balance of carbohydrate and lipid utilization during exercise: the ‘crossover’ concept. J Appl Physiol 1994; 76: 2253–2261.
- 129 Pérez-Martin A, Raynaud E, Aissa-Benhaddad A, Brun J-F & Mercier J. Preliminary evidence for a lower crossover point during exercise in obesity. Int J Obes 1999; 23: S74.
- 130 Van Aggel-Leijssen DPC, Saris WHM & Van Baak MA. The effect of exercise training at different intensities on respiratory exchange ratio (RER) of obese men. Int J Obes 1998; 22: S283.
- 131 Thompson DL, Townsend KM, Boughey R, Patterson K & Basset DR. Substrate use during and following moderate- and low-intensity exercise: implications for weight control. Eur J Appl Physiol 1998; 78: 43–49.DOI: 10.1007/s004210050385
- 132 Andersen RE, Wadden TA, Bartlett SJ, Zemel B, Verde TJ & Franckowiak C. Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial. JAMA 1999; 281: 335–340.